Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Intrinsic islet heterogeneity and gap junction coupling determine spatiotemporal Ca²⁺ wave dynamics.

Benninger RK, Hutchens T, Head WS, McCaughey MJ, Zhang M, Le Marchand SJ, Satin LS, Piston DW.

Biophys J. 2014 Dec 2;107(11):2723-33. doi: 10.1016/j.bpj.2014.10.048. Epub 2014 Dec 2.

2.

Connexin 36 mediates blood cell flow in mouse pancreatic islets.

Short KW, Head WS, Piston DW.

Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E324-31. doi: 10.1152/ajpendo.00523.2013. Epub 2013 Dec 10.

3.

Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse.

Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK.

Diabetes. 2012 Jul;61(7):1700-7. doi: 10.2337/db11-1312. Epub 2012 Apr 17.

4.

Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet.

Benninger RK, Head WS, Zhang M, Satin LS, Piston DW.

J Physiol. 2011 Nov 15;589(Pt 22):5453-66. doi: 10.1113/jphysiol.2011.218909. Epub 2011 Sep 19.

5.

Defects in beta cell Ca²+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus.

Benninger RK, Remedi MS, Head WS, Ustione A, Piston DW, Nichols CG.

Diabetologia. 2011 May;54(5):1087-97. doi: 10.1007/s00125-010-2039-7. Epub 2011 Jan 27.

6.

Quantitative measurement of zinc secretion from pancreatic islets with high temporal resolution using droplet-based microfluidics.

Easley CJ, Rocheleau JV, Head WS, Piston DW.

Anal Chem. 2009 Nov 1;81(21):9086-95. doi: 10.1021/ac9017692.

7.

Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets.

Nyman LR, Wells KS, Head WS, McCaughey M, Ford E, Brissova M, Piston DW, Powers AC.

J Clin Invest. 2008 Nov;118(11):3790-7. doi: 10.1172/JCI36209. Epub 2008 Oct 9.

8.

Gap junction coupling and calcium waves in the pancreatic islet.

Benninger RK, Zhang M, Head WS, Satin LS, Piston DW.

Biophys J. 2008 Dec;95(11):5048-61. doi: 10.1529/biophysj.108.140863. Epub 2008 Sep 19.

9.

Dimethyl amiloride improves glucose homeostasis in mouse models of type 2 diabetes.

Gunawardana SC, Head WS, Piston DW.

Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1097-108. doi: 10.1152/ajpendo.00748.2007. Epub 2008 Apr 15.

10.

Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction.

Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW.

Diabetes. 2007 Sep;56(9):2328-38. Epub 2007 Jun 15.

11.

Mechanisms of time-dependent potentiation of insulin release: involvement of nitric oxide synthase.

Gunawardana SC, Rocheleau JV, Head WS, Piston DW.

Diabetes. 2006 Apr;55(4):1029-33.

12.

Critical role of gap junction coupled KATP channel activity for regulated insulin secretion.

Rocheleau JV, Remedi MS, Granada B, Head WS, Koster JC, Nichols CG, Piston DW.

PLoS Biol. 2006 Feb;4(2):e26. Epub 2006 Jan 17.

13.

Amiloride derivatives enhance insulin release in pancreatic islets from diabetic mice.

Gunawardana SC, Head WS, Piston DW.

BMC Endocr Disord. 2005 Dec 8;5:9.

14.

Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene.

Park SY, Wang X, Chen Z, Powers AC, Magnuson MA, Head WS, Piston DW, Bell GI.

Genesis. 2005 Oct;43(2):80-6.

PMID:
16108006
15.

Imaging Beta cell development in real-time using pancreatic explants from mice with green fluorescent protein-labeled pancreatic Beta cells.

Gunawardana SC, Hara M, Bell GI, Head WS, Magnuson MA, Piston DW.

In Vitro Cell Dev Biol Anim. 2005 Jan-Feb;41(1-2):7-11.

PMID:
15926862
16.

Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2+ activity oscillations in pancreatic islets.

Rocheleau JV, Walker GM, Head WS, McGuinness OP, Piston DW.

Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):12899-903. Epub 2004 Aug 18.

17.

Nutrient-stimulated insulin secretion in mouse islets is critically dependent on intracellular pH.

Gunawardana SC, Rocheleau JV, Head WS, Piston DW.

BMC Endocr Disord. 2004 Jun 11;4(1):1.

18.

Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response.

Rocheleau JV, Head WS, Piston DW.

J Biol Chem. 2004 Jul 23;279(30):31780-7. Epub 2004 May 17.

19.

Pancreatic islet beta-cells transiently metabolize pyruvate.

Rocheleau JV, Head WS, Nicholson WE, Powers AC, Piston DW.

J Biol Chem. 2002 Aug 23;277(34):30914-20. Epub 2002 Jun 17.

20.

Differences in virulence between two Candida albicans strains in experimental keratitis.

O'Day DM, Head WS, Csank C, Shetlar DJ, Robinson RD, McCollum GW, Yang R, Zhu TL, Wang MX.

Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1116-21.

PMID:
10752949
21.

Advances in the management of keratomycosis and Acanthamoeba keratitis.

O'Day DM, Head WS.

Cornea. 2000 Sep;19(5):681-7. Review.

PMID:
11009320
22.

Identification and characterization of TUP1-regulated genes in Candida albicans.

Braun BR, Head WS, Wang MX, Johnson AD.

Genetics. 2000 Sep;156(1):31-44.

23.

Contact lens-induced infection--a new model of Candida albicans keratitis.

O'Day DM, Head WS, Robinson RD, Yang R, Shetlar D, Wang MX.

Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1607-11.

PMID:
10359345
24.

Development of a chitin assay for the quantification of fungus.

Lamps CA, Oeltmann TN, Collins MJ Jr, Robinson RD, Logan RA, Head WS, O'Day DM.

Curr Eye Res. 1995 Aug;14(8):637-41.

PMID:
8529398
25.

The relationship of corneal epithelial defect size to drug penetration.

Johnson DA, Johns KJ, Robinson RD, Head WS, O'Day DM.

Arch Ophthalmol. 1995 May;113(5):641-4.

PMID:
7748136
26.

Ocular pharmacokinetics of orally administered azithromycin in rabbits.

O'Day DM, Head WS, Foulds G, Robinson RD, Williams TE, Ferraina RA.

J Ocul Pharmacol. 1994 Winter;10(4):633-41.

PMID:
7714407
27.

The qualitative evaluation of the pharmacokinetics of subconjunctivally injected antifungal agents in rabbits.

Klippenstein K, O'Day DM, Robinson RD, Williams TE, Head WS.

Cornea. 1993 Nov;12(6):512-6.

PMID:
8261783
28.

Ocular pharmacokinetics of saperconazole in rabbits. A potential agent against keratomycoses.

O'Day DM, Head WS, Robinson RD, Williams TE, Wolff R.

Arch Ophthalmol. 1992 Apr;110(4):550-4. Erratum in: Arch Ophthalmol 1992 Nov;110(11):1597.

PMID:
1562266
29.

The evaluation of therapeutic responses in experimental keratomycosis.

O'Day DM, Head WS, Robinson RD, Williams TE, Gedde S.

Curr Eye Res. 1992 Jan;11(1):35-44.

PMID:
1313750
30.

Anomalous effect of subconjunctival miconazole on Candida albicans keratitis in rabbits.

O'Day DM, Head WS, Robinson RD, Williams TE, Gedde SJ.

Am J Ophthalmol. 1991 Nov 15;112(5):562-6.

PMID:
1951595
31.

Influence of corticosteroid on experimentally induced keratomycosis.

O'Day DM, Ray WA, Head WS, Robinson RD, Williams TE.

Arch Ophthalmol. 1991 Nov;109(11):1601-4.

PMID:
1755744
32.

Toxicity and pharmacokinetics of subconjunctival amphotericin B. An experimental study.

O'Day DM, Smith R, Stevens JB, Williams TE, Robinson RD, Head WS.

Cornea. 1991 Sep;10(5):411-7.

PMID:
1935140
33.

Differences in response in vivo to amphotericin B among Candida albicans strains.

O'Day DM, Ray WA, Robinson RD, Head WS, Williams TE.

Invest Ophthalmol Vis Sci. 1991 Apr;32(5):1569-72.

PMID:
2016138
34.

Acanthamoeba keratitis following keratoplasty without other identifiable risk factors.

Parrish CM, Head WS, O'Day DM, Rowlett W.

Arch Ophthalmol. 1991 Apr;109(4):471. No abstract available.

PMID:
2012540
35.

Examination of the contact lens with light microscopy: an aid in diagnosis of Acanthamoeba keratitis.

Johns KJ, Head WS, Robinson RD, Williams TE, O'Day DM.

Rev Infect Dis. 1991 Mar-Apr;13 Suppl 5:S425. No abstract available.

PMID:
2047685
36.

An evaluation of intrastromal injection of antifungal agents.

O'Day DM, Head WS, Robinson RD, Williams TE.

J Ocul Pharmacol. 1991 Winter;7(4):325-8.

PMID:
1809791
37.

Ocular uptake of fluconazole following oral administration.

O'Day DM, Foulds G, Williams TE, Robinson RD, Allen RH, Head WS.

Arch Ophthalmol. 1990 Jul;108(7):1006-8.

PMID:
2369337
38.

Measurements of antifungal levels in corneal tissue: a simplified bioassay for amphotericin B.

Williams TE, O'Day DM, Head WS, Robinson RD.

Graefes Arch Clin Exp Ophthalmol. 1990;228(6):538-40.

PMID:
2265769
39.

Examination of hydrophilic contact lenses with light microscopy to aid in the diagnosis of Acanthamoeba keratitis.

Johns KJ, Head WS, Parrish CM, Williams TE, Robinson RD, O'Day DM.

Am J Ophthalmol. 1989 Sep 15;108(3):329-31. No abstract available.

PMID:
2774043
40.

Corneal toxicity of propamidine.

Johns KJ, Head WS, O'Day DM.

Arch Ophthalmol. 1988 Jan;106(1):68-9. Erratum in: Arch Ophthalmol 1988 Nov;106(11):1504.

PMID:
3337709
41.

In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.

O'Day DM, Ray WA, Robinson RD, Head WS, Savage AM.

Invest Ophthalmol Vis Sci. 1987 May;28(5):874-80.

PMID:
3553060
42.

Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.

O'Day DM, Ray WA, Robinson RD, Head WS.

Invest Ophthalmol Vis Sci. 1987 Mar;28(3):596-603.

PMID:
3549613
43.

The influence of yeast growth phase in vivo on the efficacy of topical polyenes.

O'Day DM, Ray WA, Robinson RD, Head WS, Savage AM.

Curr Eye Res. 1987 Feb;6(2):363-8.

PMID:
3552454
44.
45.

Herpes simplex masquerade syndrome: acanthamoeba keratitis.

Johns KJ, O'Day DM, Head WS, Neff RJ, Elliott JH.

Curr Eye Res. 1987 Jan;6(1):207-12.

PMID:
3829702
46.

Corneal penetration of topical amphotericin B and natamycin.

O'Day DM, Head WS, Robinson RD, Clanton JA.

Curr Eye Res. 1986 Nov;5(11):877-82.

PMID:
3490954
47.

Bioavailability and penetration of topical amphotericin B in the anterior segment of the rabbit eye.

O'Day DM, Head WS, Robinson RD, Clanton JA.

J Ocul Pharmacol. 1986 Fall;2(4):371-8.

PMID:
3503121
48.

Statistical analysis for experimental models of ocular disease: continuous response measures.

Ray WA, O'Day DM, Head WS, Robinson R.

Curr Eye Res. 1985 May;4(5):585-97.

PMID:
4017643
49.

Intraocular penetration of systemically administered antifungal agents.

O'Day DM, Head WS, Robinson RD, Stern WH, Freeman JM.

Curr Eye Res. 1985 Feb;4(2):131-4. Erratum in: Curr Eye Res 1986 Jul;5(7):547.

PMID:
3987346
50.

Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.

O'Day DM, Ray WA, Head WS, Robinson RD.

Invest Ophthalmol Vis Sci. 1984 Jul;25(7):851-4.

PMID:
6735649

Supplemental Content

Support Center